PEAK6 Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$952K Sell
14,200
-9,500
-40% -$780K ﹤0.01% 1943
2024
Q2
$2.69M Sell
23,700
-5,400
-19% -$683K 0.01% 1182
2024
Q1
$4.04M Sell
29,100
-66,800
-70% -$8.4M 0.01% 954
2023
Q4
$11.9M Sell
95,900
-59,200
-38% -$6.05M 0.04% 406
2023
Q3
$14.5M Buy
155,100
+151,100
+3,778% +$17M 0.07% 259
2023
Q2
$514K Sell
4,000
-42,600
-91% -$5.15M ﹤0.01% 2198
2023
Q1
$5.41M Buy
46,600
+16,500
+55% +$1.85M 0.03% 665
2022
Q4
$3.41M Buy
30,100
+14,500
+93% +$1.59M 0.02% 937
2022
Q3
$1.26M Sell
15,600
-35,300
-69% -$2.99M 0.01% 1976
2022
Q2
$4.01M Buy
50,900
+47,700
+1,491% +$4.35M 0.01% 1579
2022
Q1
$409K Sell
3,200
-130,000
-98% -$14.2M ﹤0.01% 3322
2021
Q4
$17.9M Sell
133,200
-27,600
-17% -$3.97M 0.04% 457
2021
Q3
$22M Buy
160,800
+20,400
+15% +$2.57M 0.05% 350
2021
Q2
$15M Buy
140,400
+24,800
+21% +$2.38M 0.04% 491
2021
Q1
$10.4M Sell
115,600
-265,200
-70% -$24.9M 0.03% 616
2020
Q4
$35.2M Buy
380,800
+47,200
+14% +$4.21M 0.07% 241
2020
Q3
$34.4M Buy
333,600
+102,400
+44% +$10.7M 0.08% 197
2020
Q2
$23.4M Buy
231,200
+22,800
+11% +$2.04M 0.08% 223
2020
Q1
$14M Sell
208,400
-44,800
-18% -$2.79M 0.08% 240
2019
Q4
$13.8M Hold
253,200
0.07% 288
2019
Q3
$9.45M Buy
253,200
+201,600
+391% +$7.83M 0.06% 383
2019
Q2
$1.93M Buy
+51,600
New +$1.62M 0.01% 1316

Other funds holding DXCM

PEAK6 Investments's DXCM Position: Q3 2024 in Review

PEAK6 Investments sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,890 shares — an estimated $155K sold.

PEAK6 Investments first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $4.94M in Q4 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • PEAK6 Investments reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,890 DexCom shares in Q3 2024, an estimated $155K.
  • PEAK6 Investments first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • PEAK6 Investments's DexCom position peaked at $4.94M in Q4 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.